FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

DoubleTree by Hilton Washington DC/Silver Spring 

8727 Colesville Road, Silver Spring, Maryland 

May 10, 2012 

MEETING ROSTER 

 

 

 

DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Paul T. Tran, R.Ph  
Division of Advisory Committee and Consultant Management  
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) 
                                                                                                  
Vera A. Bittner, M.D., M.S.P.H. 
Professor of Medicine 
Section Head, Preventive Cardiology 
The University of Alabama at Birmingham 
Birmingham, Alabama 
 
Erica H. Brittain, Ph.D. 
Mathematical Statistician  
Biostatistics Research Branch 
National Institute of Allergy and Infectious Diseases 
(NIAID), National Institutes of Health (NIH) 
Bethesda, Maryland 
 
David M. Capuzzi, M.D., Ph.D. 
Professor of Medicine and Biochemistry 
Thomas Jefferson University & 
Lankenau Institute for Medical Research 
Philadelphia, Pennsylvania 

Edward W. Gregg, Ph.D. 
Chief, Epidemiology and Statistics Branch 
Division of Diabetes Translation 
Centers for Disease Control and Prevention (CDC) 
Atlanta, Georgia  
 
Ida J. Spruill, Ph.D., R.N. 
(Consumer Representative) 
Assistant Professor, College of Nursing 
Medical University of South Carolina 
Charleston, South Carolina 
 

Abraham Thomas, M.D., M.P.H., FACP 
(Chairperson) 
Division Head, Endocrinology, Diabetes, Bone, and 
Mineral Disorders 
Henry Ford Hospital 
Whitehouse Chair of Endocrinology 
Detroit, Michigan  
 
Lamont G. Weide, M.D., Ph.D., FACE 
Chief, Diabetes & Endocrinology 
Professor, Internal Medicine  
University of Missouri - Kansas City 
Truman Medical Centers, Diabetes Center 
Kansas City, Missouri 
 
 

Eric I. Felner, M.D., MSCR 
Associate Professor of Pediatrics 
Division of Pediatric Endocrinology 
Director, Pediatric Endocrinology Fellowship Program 
Emory University School of Medicine 
Atlanta, Georgia 

 
 
 
 
 
 

Page 1 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

DoubleTree by Hilton Washington DC/Silver Spring 

8727 Colesville Road, Silver Spring, Maryland 

 

May 10, 2012 

MEETING ROSTER (cont.) 

 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBER (Non-Voting) 
 
Mads F. Rasmussen, M.D., Ph.D. 
(Industry Representative) 
Executive Director 
Diabetes - Clinical Development and Research 
Clinical Development, Medical and Regulatory 
Affairs, Novo Nordisk Inc.  
Princeton, New Jersey 
 
TEMPORARY MEMBERS (Voting) 
 
Daniel H. Bessesen, M.D. 
Professor of Medicine 
University of Colorado School of Medicine 
Chief of Endocrinology  
Denver Health Medical Center 
Denver, Colorado 
 
Heidi M. Connolly, M.D. 
Professor of Medicine 
Consultant in Cardiovascular Diseases  
Mayo Clinic  
Rochester, Minnesota 
 
Katherine M. Flegal, Ph.D. 
Senior Research Scientist 
Distinguished Consultant 
National Center for Health Statistics, CDC 
Hyattsville, Maryland  
 

Peter A. Gross, M.D. 
Chair 
Hackensack Physician-Hospital Alliance ACO, LLC 
Hackensack University Medical Center 
Hackensack, New Jersey 
 

Ed J. Hendricks, M.D. 
Medical Director  
Center for Weight Management  
Roseville and Sacramento, California 
 

William R. Hiatt, M.D., FACP 
Professor of Medicine, Division of Cardiology 
University of Colorado School of Medicine  
President, Colorado Prevention Center  (CPC) Clinical 
Research 
Aurora, Colorado 
 
Sanjay Kaul, M.D. 
Director, Fellowship Training Program in Cardiovascular 
Diseases 
Cedars-Sinai Heart Institute 
Professor, David Geffen School of Medicine at UCLA 
Division of Cardiology 
Cedar Sinai Medical Center 
Los Angeles, California 

Allison B. Goldfine, M.D. 
Assistant Director of Clinical Research 
Joslin Diabetes Center, Research Division 
Boston, Massachusetts 

 

 

 

 
 
 
 

Page 2 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

DoubleTree by Hilton Washington DC/Silver Spring 

8727 Colesville Road, Silver Spring, Maryland 

 

May 10, 2012 

MEETING ROSTER (cont.) 

 

 

 
TEMPORARY MEMBERS (Voting) 
 
David E. Malarkey D.V.M., Ph.D., DACVP 
Head, National Toxicology Program Pathology Group 
Cellular and Molecular Pathology Branch 
National Institute of Environmental Health Sciences 
(NIEHS), NIH 
Research Triangle Park, North Carolina 
 
Ernest E. McConnell, D.V.M., M.S. 
President of Toxpath, Inc. 
Veterinary Pathology  
Raleigh, North Carolina 
 
Lewis S. Nelson, M.D. 
Professor of Emergency Medicine 
Director, Fellowship in Medical Toxicology 
New York University School of Medicine 
New York City Poison Control Center 
New York, New York 
 

Jeanmarie Perrone, M.D., FACMT 
Associate Professor, Emergency Medicine 
Director, Division of Medical Toxicology 
University of Pennsylvania School of Medicine 
Philadelphia, Pennsylvania 
 
FDA PARTICIPANTS (Non-Voting) 
 
Curtis J. Rosebraugh, M.D., M.P.H. 
Director 
Office of Drug Evaluation II (ODE-II)  
Office of New Drugs (OND), CDER, FDA 
 
Todd Bourcier, Ph.D.  
Supervisory Pharmacologist 
DMEP, ODE-II, OND, CDER, FDA 
 
Fred Alavi, Ph.D.  
Pharmacologist 
DMEP, ODE-II, OND, CDER, FDA 
 

 

Page 3 of 3 

Robert J. Smith, M.D. 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
East Providence, Rhode Island 
 

Angelica Walden  
(Patient Representative) 
Hephzibah, Georgia 

Jack A. Yanovski, M.D., Ph.D. 
Chief, Section on Growth and Obesity 
Program in Developmental Endocrinology and Genetics 
(PDEGEN) 
Eunice Kennedy Shriver National Institute of Child 
Health and Human Development (NICHD), NIH 
Bethesda, Maryland 
 
 

  
 

Eric C. Colman, M.D. 
Deputy Director 
Division of Metabolism and Endocrinology Products 
(DMEP), ODE-II, OND, CDER, FDA 
 
Julie Golden, M.D. 
Medical Reviewer 
DMEP, ODE-II, OND, CDER, FDA 
 
 

